Thai scientists race to develop homemade COVID-19 vaccine amid second wave of infections

As the Thai government races to secure more COVID-19 vaccines from various sources, a group of medical scientists is preparing for the first clinical trial of a home-grown cure they are developing to fight the pandemic.

123123213123
Thai scientists race to develop homemade COVID-19 vaccine amid second wave of infections

In April, they expect to inject 72 volunteers aged between 18 and 75 with ChulaCov19 – a vaccine that is being developed by the Medicine Faculty of Chulalongkorn University in Bangkok to fight the infectious disease. “We’ll inject our first volunteer in April, probably around the end of the month. Within two months, we should know the results of Phase 1, which will show what appropriate dosages will be,” said Kiat Ruxrungtham, professor of medicine and director of Chulalongkorn University’s vaccine research centre – Chula VRC.

Globally, there are several types of vaccine technologies being used for COVID-19. ChulaCov19 employs Messenger RNA or mRNA, which enables the body to produce a protein that triggers an immune response to the virus. The technology is used by leading pharmaceutical companies such as Moderna, Pfizer and BioNTech. They have released data backed by large-scale clinical trials indicating that their vaccines are more than 90 per cent effective in preventing the disease in humans.

Other types include viral vector technology, which is used by AstraZeneca and Oxford University, and inactivated vaccines such as CoronaVac by China’s Sinovac Biotech. “We chose mRNA because we believe it is a technology of the future. It has also been proven that this technology developed the fastest and reported 94 per cent to 95 per cent efficacy in humans, which is the highest rate,” Kiat told CNA.

His team expects to complete Phase 1 in June. They will then move on to Phase 2 and later Phase 2B with 600 and 5,000 volunteers respectively. If all goes as planned, Kiat added, ChulaCov19 could be manufactured in Thailand by the end of this year. “We’re doing two things in parallel. We’re hiring factories overseas to produce the vaccine for testing in volunteers and at the same time preparing a factory in Thailand for manufacture by the end of this year,” he said.

Source: Chulalongkorn University

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Next Post

Surrey project to address the problem of indoor air pollution affecting millions in developing countries

Tue Jan 26 , 2021
According to the World Health Organisation, indoor air pollution exposure leads to 4.3million premature deaths globally. In low-income homes, particularly in developing countries, poor ventilation and inefficient cooking methods expose many to poor indoor air quality. Surrey’s Global Centre for Clean Air Research (GCARE) will work with partners across 11 Official Development […]

European Higher Education Organization is a public organization carrying out academic, educational and information activities on higher education in Europe.

The EHEO general plan stresses that:

  • Higher education systems require adequate funding and, as an investment in economic growth, public spending in higher education should be protected.
  • The challenges faced by higher education require more flexible governance and funding systems, which balance greater autonomy for education institutions with accountability to stakeholders.

Thus, EHEO plans:

  • improve academic and scientific interaction of universities;
  • protect the interests of universities;
  • interact more closely with public authorities of European countries;
  • popularize European higher education in the world;
  • develop academic mobility;
  • seek funding for European universities.